NDC 70710-1531-01

Liposomal doxorubicin injection at Lucile Salter Packard Children's Hospital At Stanford

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION|DISCARDED DRUG NOT ADMINISTE

PALO ALTO, CA

See all hospitals reporting NDC 70710-1531-01 →

SharePost on X LinkedIn

Pricing by billing methodology

Price type

How this price compares nationally

Lucile Salter Packard Children's Hospital At Stanford’s median price of $3.5k is 640% above the median hospital's median price ($475), higher than 85% of the 235 hospitals reporting NDC 70710-1531-01. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Mar 31, 2026

Compare to other hospitals

See Liposomal doxorubicin injection pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.